GB1406062A - Medicament formulations containing 6-methoxypyridazinium compounds - Google Patents

Medicament formulations containing 6-methoxypyridazinium compounds

Info

Publication number
GB1406062A
GB1406062A GB1315075A GB1315075A GB1406062A GB 1406062 A GB1406062 A GB 1406062A GB 1315075 A GB1315075 A GB 1315075A GB 1315075 A GB1315075 A GB 1315075A GB 1406062 A GB1406062 A GB 1406062A
Authority
GB
United Kingdom
Prior art keywords
dosage unit
methoxypyridazinium
compounds
formulations containing
medicament formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1315075A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of GB1406062A publication Critical patent/GB1406062A/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1406062 Medicament formulations BASF AG 4 Aug 1972 [7 Aug 1971] 13150/72 Divided out of 1406061 Heading A5B A medicament formulation for use as a cardiac stimulating or vasopressor agent in humans by parenteral administration comprises a 1-phenyl-4-amino-6-methoxy-pyridazinium salt with a therapeutically acceptable anion in dosage unit form for parenteral administration, each dosage unit containing up to 10mg of the active ingredient, or by peroral administration in dosage unit form for peroral administration each dosage unit containing up to 70mg of the active ingredient.
GB1315075A 1971-08-07 1972-08-04 Medicament formulations containing 6-methoxypyridazinium compounds Expired GB1406062A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712139687 DE2139687C2 (en) 1971-08-07 1971-08-07 Use of compounds in increasing blood pressure

Publications (1)

Publication Number Publication Date
GB1406062A true GB1406062A (en) 1975-09-10

Family

ID=5816135

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1315075A Expired GB1406062A (en) 1971-08-07 1972-08-04 Medicament formulations containing 6-methoxypyridazinium compounds
GB3649972A Expired GB1406061A (en) 1971-08-07 1972-08-04 Medicament formulations containing 6-alkoxypyridzinium compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB3649972A Expired GB1406061A (en) 1971-08-07 1972-08-04 Medicament formulations containing 6-alkoxypyridzinium compounds

Country Status (5)

Country Link
BE (1) BE787275A (en)
DE (1) DE2139687C2 (en)
FR (1) FR2150745B1 (en)
GB (2) GB1406062A (en)
ZA (1) ZA725359B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3144138A1 (en) * 1981-11-06 1983-05-19 Basf Ag, 6700 Ludwigshafen NEW PYRIDAZINONIMINE AND THEIR PHYSIOLOGICALLY COMPATIBLE ACID ADDITION SALTS, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC AGENTS CONTAINING THESE COMPOUNDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1912941C3 (en) * 1969-03-14 1980-06-26 Basf Ag, 6700 Ludwigshafen 1-phenyl ^ -amino-e-methoxypyridazinium salts

Also Published As

Publication number Publication date
FR2150745B1 (en) 1976-08-20
ZA725359B (en) 1973-05-30
FR2150745A1 (en) 1973-04-13
GB1406061A (en) 1975-09-10
BE787275A (en) 1973-02-07
DE2139687C2 (en) 1985-01-24
DE2139687A1 (en) 1973-02-15

Similar Documents

Publication Publication Date Title
MY174339A (en) 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
GB1406062A (en) Medicament formulations containing 6-methoxypyridazinium compounds
GB1363047A (en) Pyrimidine derivative process for its preparation and its use as a medicament
GB1362845A (en) Benzyl alcohol derivatives
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
GB1125924A (en) Organic bismuth derivative
IL30488A (en) Pharmaceutical compositions comprising as an active ingredient p-benzoylphenylacetic acid,o-benzoylphenylacetic acid or salts thereof
GB1375806A (en)
GB1424611A (en) Pharmaceutical compositions
ES424636A1 (en) Pharmaceutical compositions comprising mixed salts of sulfoglycopeptides with metal and organic bases
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
GB1088466A (en) Medicaments comprising 5-nitrouracil
GB1168302A (en) Aluminium N-Acetylglycinate and Pharmaceutical Compositions containing the same
GB1246727A (en) Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids
IE36780L (en) Pharmaceutical preparations
GB1246733A (en) Salts of aminoquinaldine derivative and preparation thereof
ES341427A1 (en) Pyrazine derivatives
GB1460577A (en) Antibacterial compsotions
GB1050396A (en)
GB1287433A (en) Pharmaceutical compositions
ES363792A1 (en) 2-Sulfanilamido-3-Halogeno-Pyridines
ES383340A1 (en) P-(acetoacetamidoalkyl)benzenesulfonamide derivatives
GB1109964A (en) Complex of theophylline and soluble saccharin, process for its preparation and therapeutic composition comprising same

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years